Losartan Potassium Active Pharmaceutical Ingredient (API) Market Outlook 2025 – Insights for Executive and Strategic Planning
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Losartan Potassium Active Pharmaceutical Ingredient (API) Market Grown from 2024 to 2025?
The market for Losartan Potassium Active Pharmaceutical Ingredient (API) has seen significant expansion in the past few years. Projected to escalate from a value of $1.75 billion in 2024 to $1.87 billion in 2025, it is anticipated to grow at a Compound Annual Growth Rate (CAGR) of 7.0%. The market’s prosperity in the historical period stems from an escalated utilization of antihypertensive medications, a heightened occurrence of lifestyle-related illnesses, a surge in consciousness regarding cardiovascular health, a global increase in healthcare spending, and a growing demand for cost-effective generic drugs.
What Growth Rate Is Anticipated for the Losartan Potassium Active Pharmaceutical Ingredient (API) Market in the Coming Years?
A significant surge is projected in the size of the losartan potassium active pharmaceutical ingredient (API) market in the coming years. It is speculated to rise to $2.44 billion in 2029, boasting a compound annual growth rate (CAGR) of 6.9%. The ascension in the forthcoming period can be credited to factors like a swelling number of patients dealing with chronic diseases, an increased emphasis on preemptive cardiovascular treatment, augmented reach of healthcare services in developing markets, advancements in the sphere of drug formulation technology, and intensifying governmental actions promoting generic drugs. The forecast period is likely to witness trends like the evolution of manufacturing processes, advanced drug delivery systems, the creation of formulations suitable for children, innovations intending to prolong the shelf life of the packaging, and the formulation of combination therapies including losartan.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24285&type=smp
Who Are the Leading Companies in the Losartan Potassium Active Pharmaceutical Ingredient (API) Market?
Major companies operating in the losartan potassium active pharmaceutical ingredient (API) market are Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd, Dr. Reddy’s Laboratories, Cadila Pharmaceuticals Ltd, Lupin Ltd, Zydus Lifesciences Ltd, Alkem Laboratories Ltd, IPCA Laboratories Ltd, Alembic Pharmaceuticals Ltd, Granules India Limited, Vasudha Pharma Chem Ltd, IOL Chemicals and Pharmaceuticals Limited, Unichem Laboratories Ltd, Global Pharma Tek, Hetero Drugs Ltd, Manus Aktteva Biopharma LLP, Wellona Pharma, Atom pharma, Sinoway Industrial Co. Ltd, Cerata Pharmaceuticals LLP
What Are the Key Drivers of the Losartan Potassium Active Pharmaceutical Ingredient (API) Market?
The increased incidences of hypertension are expected to fuel the expansion of the losartan potassium active pharmaceutical ingredient (API) market in the future. Hypertension is defined as consistently high blood pressure, which could increase the risk of heart disease, stroke, and other serious health problems. The escalating cases of hypertension can be associated with salt-rich and processed food diets that cause fluid retention and add strain to the heart. The function of losartan potassium is to manage hypertension by inhibiting angiotensin II, a hormone that constricts blood vessels. It aids in relaxing and dilating the vessels, thereby reducing blood pressure and making it easier for the heart to function. For example, the American Heart Association reported in January 2024 that there had been 131,454 primary deaths related to high blood pressure in 2022, which was an increase from 124,508 deaths in 2021. Hence, the rising instances of hypertension are pushing the growth of the losartan potassium active pharmaceutical ingredient (API) market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24285&type=smp
What Are the Key Market Segments in the Losartan Potassium Active Pharmaceutical Ingredient (API) Industry?
The losartan potassium active pharmaceutical ingredient (API) market covered in this report is segmented –
1) By Product Type: Tablet, Capsule, Other Product Types
2) By Production Method: Synthetic Route, Biotechnological Process, Continuous Flow Production
3) By Distribution Channel: Online Pharmacies, Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
4) By Application: Hypertension, Heart Failure, Chronic Kidney Diseases, Other Applications
5) By End-User: Hospitals, Clinics, Home Care Settings, Pharmaceutical Companies
Subsegments:
1) By Tablet: Immediate-Release Tablets, Extended-Release Tablets, Film-Coated Tablets, Orally Disintegrating Tablets
2) By Capsule: Hard Gelatin Capsules, Soft Gelatin Capsules, Modified-Release Capsules
3) By Other Product Types: Injectable Formulations, Bulk Active Pharmaceutical Ingredient (API) Powder, Granules For Suspension, Pre-Formulated Intermediates
What Are the Latest Trends in the Losartan Potassium Active Pharmaceutical Ingredient (API) Market?
Key players in the losartan potassium active pharmaceutical ingredient (API) market are concentrating on the development of unique products and securing approvals, such as the losartan potassium oral suspension, to improve patient adherence and broaden therapeutic uses. The losartan potassium oral suspension represents a liquid variant of the losartan potassium medication, specifically designed for those who have difficulty swallowing pills. For example, in March 2025, Scienture Holdings Inc., a biopharmaceutical firm from the US, obtained approval from the Food and Drug Administration (FDA) for Arbli. Arbli is a ready-to-use liquid formula aimed at reducing stroke risk in hypertensive patients with left ventricular hypertrophy, controlling hypertension, and managing diabetic nephropathy in patients with type 2 diabetes. It delivers accurate dosage without the need for compounding and is offered as a 165 mL peppermint-flavored suspension (10 mg/mL) with an 18-month room temperature shelf life.
Access The Full Report Here:
What Are the Key Regional Markets in the Losartan Potassium Active Pharmaceutical Ingredient (API) Industry?
North America was the largest region in the losartan potassium API market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the losartan potassium active pharmaceutical ingredient (API) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/customise?id=24285&type=smp
This Report Delivers Insight On:
1. How big is the losartan potassium active pharmaceutical ingredient (api) market, and how is it changing globally?
2. Who are the major companies in the losartan potassium active pharmaceutical ingredient (api) market, and how are they performing?
3. What are the key opportunities and risks in the losartan potassium active pharmaceutical ingredient (api) market right now?
4. Which products or customer segments are growing the most in the losartan potassium active pharmaceutical ingredient (api) market?
5. What factors are helping or slowing down the growth of the losartan potassium active pharmaceutical ingredient (api) market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
